Core Laboratories
CLB
207 hedge funds and large institutions have $476M invested in Core Laboratories in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 80 increasing their positions, 67 reducing their positions, and 104 closing their positions.
230% more call options, than puts
Call options by funds: $6.42M | Put options by funds: $1.94M
19% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 67
1.77% less ownership
Funds ownership: 105.39% → 103.62% (-1.8%)
27% less funds holding
Funds holding: 283 → 207 (-76)
71% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 104
73% less capital invested
Capital invested by funds: $1.76B → $476M (-$1.29B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
+$83.4M |
| 2 |
Goldman Sachs
New York
|
+$74.8M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$26M |
| 4 |
Renaissance Technologies
New York
|
+$18.2M |
| 5 |
LM
Luminus Management
Houston,
Texas
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$54.7M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$42.8M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$39.4M |
| 4 |
MNG
Manning & Napier Group
Fairport,
New York
|
-$26.2M |
| 5 |
JP Morgan Chase
New York
|
-$20M |
CLB Hedge Fund Activity: Q1 2020 in Review
207 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2020, worth a combined $476M — down 73% from $1.76B a quarter earlier.
Sellers outnumbered buyers: 104 funds closed out of CLB and 30 opened new positions — a net loss of 74 holders — while 67 trimmed existing stakes and 80 added.
The largest buyer was VanEck Associates, adding an estimated $83.4M. The largest seller was Select Equity Group, exiting entirely with an estimated $54.7M sold.
- 207 institutional investors held Core Laboratories (CLB) as of Q1 2020, down from 283 in Q4 2019.
- Funds reported $476M of Core Laboratories stock for Q1 2020, down 73% quarter-over-quarter.
- 30 funds opened new Core Laboratories positions in Q1 2020 and 104 closed out, a net change of -74 holders.
- The largest Core Laboratories buyer in Q1 2020 was VanEck Associates, an estimated $83.4M added.
- The largest Core Laboratories seller in Q1 2020 was Select Equity Group, an estimated $54.7M sold.
Based on aggregated 13F filings for Q1 2020.